Colgate to Aid by Innovation & Other Efforts: Should You Buy or Hold?

Colgate-Palmolive (CL) reported solid first-quarter 2025 results, driven by strong pricing actions and innovation, maintaining its leadership in the toothpaste (40.9% global market share) and manual toothbrush (31.9% global market share) markets. While the company faces macroeconomic headwinds, including inflation and unfavorable currency exchange rates (projected to have a low-single-digit negative impact on 2025 sales), management is confident in achieving its financial goals for 2025, projecting low single-digit net sales growth and 2-4% organic sales growth. The company's focus on premium products, innovation, and strategic pricing are expected to bolster margins, despite anticipated challenges in the operating landscape.

Analysis

Colgate-Palmolive (CL) demonstrated resilience in its first-quarter 2025 performance, with organic sales advancing 1.4% driven by a 1.5% improvement in pricing, leading to an 80 basis point expansion in gross margin and a 120 basis point increase in operating margin year-over-year. The company maintains significant market leadership, holding a 40.9% global share in toothpaste and 31.9% in manual toothbrushes, underpinned by a successful innovation strategy focusing on premium products like the re-launched Colgate Total and Hill's Science Diet. Despite these strengths and a 3.2% share price appreciation in the past three months, outpacing the industry's 0.7% rise, CL faces headwinds from challenging macroeconomic conditions, including inflationary pressures and tariff concerns, alongside a projected low-single-digit negative impact from unfavorable currency exchange rates on 2025 sales. Management's guidance for 2025 includes low single-digit net sales growth, 2-4% organic sales growth, a nearly flat gross profit margin, and low single-digit EPS growth, indicating a cautiously optimistic outlook supported by strategic investments in its supply chain and ongoing brand development.

Key Decisions for Investors

• Given Colgate-Palmolive's strong market position and recent margin improvements offset by modest growth forecasts and macroeconomic uncertainties, investors should consider a neutral stance, aligning with the current Zacks Rank #3 (Hold).
• Closely scrutinize the company's ability to sustain its pricing power and manage input costs, as these will be critical in achieving the guided flat gross margin and low single-digit EPS growth for 2025 amidst inflationary and currency pressures.
• Investors should monitor the evolving impact of tariffs and consumer sentiment on CL's performance, and may explore sector alternatives like Nomad Foods (NOMD), Mondelez International (MDLZ), or Utz Brands (UTZ), which are highlighted for potentially stronger growth or different risk profiles.